- recruitingPHASE1, PHASE2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
This study is testing a new drug, rezatapopt, for advanced cancers with a specific gene change (TP53 Y220C). It's also looking at rezatapopt with another drug, pembrolizumab, to see how safe and effective they are. It’s for people who have already had cancer treatment.
United States · Australia · France - recruitingNot Applicable
APPLIED-LUNG: Transforming lung cancer screening
This study is looking into a new blood test called OXcan. It aims to see if this blood test can accurately find lung cancer and help decide who truly needs a CT scan as part of NHS lung cancer screening.
United Kingdom · England - active not recruiting
Tissue Engineering Approaches to Treat COPD
This study is looking at lung tissue from people with and without COPD to understand the disease better. Researchers are also trying to create new lab-grown lung tissue to help treat lung damage, specifically focusing on how it might work with existing lung tissue.
United Kingdom - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II, single-arm trial to investigate tepotinib in advanced (locally advanced or metastatic) non-small cell lung cancer with MET exon 14 (METex14) skipping alterations or MET amplification (VISION)
This study is looking at a new medicine called tepotinib for certain types of advanced lung cancer. It aims to see how well it shrinks tumours in people with specific changes in their cancer cells (METex14 skipping or MET amplification).
Belgium · France · Poland - recruitingNA
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
This study looks at how a self-guided online tool called SELF-BREATHE helps adults with long-term breathlessness. It aims to see if using this website improves their breathing and quality of life, and if it could be used more widely in the NHS.
United Kingdom - active not recruitingPHASE1, PHASE2
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
This study is testing different combinations of new drugs, including EOS-448, with or without standard treatments for advanced cancers like lung and head & neck cancer, and melanoma. Researchers want to see if these combinations are safe and effective.
United States · Belgium · France - recruiting
Testing whether adding a quick tummy scan to routine lung cancer screening can help detect other serious illnesses earlier
This study looks at adding a quick tummy scan to routine lung cancer checks for ever-smokers aged 55-70. It aims to see if this helps find other serious conditions, like kidney cancer, earlier. Researchers want to make sure it's practical and doesn't add too much time.
United Kingdom · England - recruitingPHASE2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
This study is looking at a new treatment called HER3-DXd for people with certain advanced solid tumours that haven't responded to other treatments. It aims to see how well it works and if it's safe for different types of cancer, like melanoma, lung cancer, and breast cancer.
United States · Australia · Belgium - recruitingPHASE2
Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)
This study is testing a new breath test called OWL-EVO1 to see if it can accurately find lung cancer. It involves comparing people with lung cancer to those without, to make sure the test works well and is easy to use.
Czechia · Hungary · United Kingdom - not yet recruiting
Development of the Drug and Alcohol Respiratory Health Test
This study is creating a simple test to check lung health in adults who use certain substances. Many people with substance use disorder have breathing problems that often go unnoticed. This new test aims to find these issues early so people can get the right help.
United Kingdom - authorisedPhase II and Phase III (Integrated)
Test-Retest Evaluation of [18F]F-AraG in Lung Tumors (TREAT)
This study, called TREAT, is looking at a new way to check how lung tumours respond to treatment. It uses a special scan with a substance called [18F]F-AraG. The aim is to see if this scan can reliably measure changes in tumour activity, which could help doctors understand if a treatment is working.
Netherlands - active not recruitingPHASE3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
This study is looking into a new drug, zipalertinib, for people with a certain type of lung cancer (NSCLC) in its early stages. It compares zipalertinib with standard chemotherapy to a dummy pill (placebo) with standard chemotherapy after surgery.
United States · Argentina · Australia - recruitingPHASE1, PHASE2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
This study is looking at new combinations of medicines for advanced lung or breast cancer. We want to see if they are safe, how much medicine gets into the body, and if they show early signs of working. It's for adults with certain types of advanced cancer.
United States · Australia · Canada - ongoing, recruitingPhase I and Phase II (Integrated)- Bioequivalence Study
Phase Ib/II trial of the combination of atezolizumab with dendritic cell vaccination as maintenance treatment in patients with extensive stage small cell lung cancer (ES-SCLC) after induction treatment.
This study is looking at a new way to treat extensive small cell lung cancer. It combines a drug called atezolizumab with a special vaccine made from your own cells. The aim is to see if this combination can help people live longer without their cancer growing after initial treatment.
Spain - recruitingNA
Clinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.
This study looks at a new way to treat lung cancer called microwave ablation. It's for people with lung nodules who can't have surgery or choose not to. The study will check if the treatment works and is safe.
France · United Kingdom - active not recruiting
Analysis of Screen-detected Lung Cancers' Genomic Traits
This study looks at lung cancers found through screening to understand their unique features. Researchers want to learn more about these cancers to find better ways to check for them without needing surgery, making screening safer and more effective for everyone.
United Kingdom - recruiting
Lung cAncer Robotic Comparative Study
This study compares two keyhole surgeries for early lung cancer: robotic-assisted and video-assisted. It aims to see which method works best, helps recovery, and improves patients' quality of life when treating small lung cancers.
Denmark · France · Germany - completed
Testing whether home urine kits increase lung cancer screening participation
This study looks at whether sending home urine kits to people who haven't responded to lung cancer screening invites could encourage more participation. It aims to make it easier for people to get checked for lung cancer early.
United Kingdom · England - completedNot Applicable
A study to test an exercise and self-management application for people living with lung cancer
This study is testing a new app for people with lung cancer. It helps manage symptoms and encourages exercise at home. Researchers want to see if the app is easy to use and if it can improve how people feel and their activity levels.
United Kingdom · England - recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The MOMENTUM Study is tracking how a new type of advanced radiotherapy, called MR-Linac, works for people with different cancers. It aims to see if this treatment improves survival, controls cancer better, and enhances quality of life by using highly precise radiation guidance.
United States · Australia · Belgium - completedNot Applicable
Identifying lung disease by using novel imaging techniques
This study is testing new camera tools, Eyes on Target (EoT1) and KronoScan (KC.02), to help doctors see deeper inside the lungs during routine lung exams. The goal is to improve how doctors find and sample lung problems, especially lung cancer, to get a quicker and more accurate diagnosis.
United Kingdom · Scotland - recruitingNA
Understanding the Feasibility of a Co-designed Pre-radiotherapy Exercise Programme - A Single-arm Study
This study looks at a new exercise plan for people with lung cancer having radiotherapy. Participants cycle for 20 minutes before treatment to see if it's helpful and safe. The goal is to make treatment easier for future patients.
United Kingdom - recruiting
Nodule IMmunophenotyping Biomarker for Lung Cancer Early Diagnosis Study
This study, called NIMBLE, uses AI to look at blood tests and CT scans to better tell the difference between harmless lung growths (nodules) and lung cancer. It aims to improve early diagnosis, especially for people with a history of cancer.
United Kingdom - recruitingNA
Oxford Pleural Embolisation Trial
This study looks at a simple way to prevent a common side effect, a 'collapsed lung' (pneumothorax), after lung cancer treatment called thermal ablation. It tests if injecting a patient's own blood around the lung helps seal tiny air leaks, potentially making recovery quicker and safer.
United Kingdom - recruiting
European Real-World Registry for Use of the Ion Endoluminal System
This study looks at how well a device called the Ion Endoluminal System works in real patients. It's for people having tests for lung growths (nodules) to see if they're cancerous or to help locate them for treatment.
France · Germany · Switzerland - active not recruitingPHASE2
Study of Novel Treatment Combinations in Patients With Lung Cancer
This study looks at new drug combinations to treat lung cancer. It has three parts: for cancer that has spread, cancer that has grown despite previous treatment, and earlier-stage cancer that can be removed by surgery.
United States · Brazil · Hong Kong - recruitingPHASE1, PHASE2
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
This study looks at a new way to help surgeons find lung cancer during operations. It uses a special dye, IRDye800CW-nimotuzumab, that glows near cancer cells. Doctors want to see if it's safe, how much to use, and when to use it to help surgery be more accurate.
Canada - recruitingPHASE1, PHASE2
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
This study looks for a better way to find specific cancer cells (EGFR-positive) in lung and bowel cancers. We use a special scan (PET) after giving a small amount of a test medicine to see if it lights up these cancer cells, helping doctors choose the best treatments.
Canada - recruitingPHASE3
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
This study looks at new ways to help people having surgery for lung, stomach, or food pipe cancer. It aims to reduce problems after surgery, improve quality of life, and explore how natural health approaches might help alongside standard care.
Canada - recruitingNA
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)
This study looks at a special test called EBUS-TBNA for people with early lung cancer who can't have surgery. The test helps doctors understand if the cancer has spread to nearby glands, which helps decide if a modern radiation treatment (SBRT) is suitable.
Canada - recruitingNA
Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
This study in Lyon, France, is collecting information and samples from people with lung cancer and similar chest cancers. Researchers want to learn more about these cancers to help improve treatments in the future. It involves giving blood and answering questionnaires.
France - active not recruiting
Radiograph Accelerated Detection and Identification of Cancer in the Lung
This study looks at how a new computer program called qXR, which uses artificial intelligence (AI), can help doctors find lung cancer earlier. It checks chest X-rays to spot possible problems, aiming to improve diagnosis and treatment for people in the UK.
United Kingdom - recruiting
DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution
This study checks if an AI tool helps doctors decide the best care for lung lumps. It aims to see if using AI improves patient health and saves money compared to current methods for managing these lumps.
United Kingdom - recruiting
AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
This study uses computers to analyse scans of new lung spots in people who've had cancer. It aims to help doctors tell if these spots are harmless, a new cancer, or cancer spread, to improve diagnosis and care.
United Kingdom - recruitingPHASE4
PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
This study looks at how well older people (70+) with specific lung cancer are treated with standard medicines. It collects real-world information about their health, treatments, safety, and how their quality of life is affected.
France - recruiting
An Observational Study of Predictors and Outcomes of Lung Cancer in Never-smokers in the UK
This study looks at lung cancer in people in the UK who have never smoked. Researchers want to understand why non-smokers get lung cancer and find ways to diagnose it earlier and improve treatment. Taking part won't change your usual medical care.
United Kingdom - recruiting
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)
This study looks at treating abdominal and lung cancers using a new type of radiotherapy machine, called an MR-Linac. It aims to see if this machine can deliver very precise radiation to tumours while better protecting healthy tissues, and how it affects the patient experience.
United Kingdom - active not recruitingPHASE3
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
This study looks at a new way to give a lung cancer medicine called pembrolizumab. It compares giving it through a drip in your arm (IV) versus a new injection under the skin (SC) for people with advanced non-small cell lung cancer. Researchers want to see how the injection works.
United States · China · Germany - active not recruiting
Bronchoscopic Microwave Ablation of Lung Tissue
This study looks at a new way to treat lung cancer using a special tool to heat and remove small growths (nodules) in the lungs. It aims to see how safe and effective this treatment is for patients.
Netherlands · United Kingdom - recruitingNA
Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway
This study looks for early signs of lung cancer in people at risk, especially those with heart disease linked to smoking. They'll use blood and stool samples, along with special X-rays, to find new ways to detect cancer sooner and help people stop smoking.
France - recruitingNA
First in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System
This study is testing a new system called EAS1 to treat lung cancer. It's the first time this system is being used in humans. Doctors want to see if it's safe and if it works well for people with early-stage lung cancer who could also have surgery.
Israel · Spain · United Kingdom - recruitingPHASE2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
This study is testing a new oral medicine, APL-101, for people with advanced cancers. It focuses on lung cancer and other solid tumours where specific genetic changes linked to a protein called MET are found. Researchers want to see how well it works and if it's safe.
United States · Australia · Canada - recruiting
Should low-dose CT be used instead of chest X-ray to screen patients for lung cancer when they have possible symptoms?
This study looks at whether a special type of X-ray called a low-dose CT scan is better than a regular chest X-ray for finding lung cancer early in people with symptoms. Finding cancer earlier often means better treatment outcomes, but CT scans have some downsides.
United Kingdom · England - recruitingPHASE2
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
Researchers are studying if high-dose vitamin C given into the veins, alongside standard chemotherapy for advanced lung cancer, can be helpful. This study will compare vitamin C to a dummy treatment in people with advanced non-small cell lung cancer.
Canada - active not recruiting
SCOOT: Sample Collection for DART
This study helps find lung health problems, especially lung cancer, earlier. We use a blood sample to create new computer tools. These tools aim to speed up diagnosis and help doctors choose the best treatment faster for people aged 55-75 with certain lung findings.
United Kingdom - active not recruiting
Resistance to the Tyrosine Kinase Inhibitor Osimertinib and Pharmacokinetics in Non-small Cell Lung Cancer
This study looks at how a lung cancer drug called osimertinib works in the body and why it sometimes stops being effective. Researchers want to understand if different drug levels in the blood affect how well it works and if this could help prevent the cancer from coming back.
France - recruitingNA
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
This study looks at how combined radiation and chemotherapy for lung or head and neck cancers affects the body's natural cancer-fighting cells. Researchers hope to understand these immune responses better to improve future treatments.
France - recruitingPHASE1
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
This study is testing a new medicine, DO-2, for people with advanced solid tumours, especially lung cancer, that have specific genetic changes and where other treatments haven't worked. It aims to see if DO-2 is safe and how it moves through the body.
Belgium · France · Netherlands - recruitingNA
Clinico-biological Data Collection Study of Metastatic Lung Cancer
This study is gathering information from people with advanced lung cancer. We want to understand why treatments work for some and not others by looking at different pieces of information like health, lifestyle, and tumour details. This could help doctors choose better treatments in the future.
France - recruitingPHASE2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
This study looks at a medicine called atezolizumab for different cancers. We want to see if a special test of your cancer cells can predict if the medicine will work well for you. This helps us learn more about tailoring treatments.
Canada